Global Inhalable Drugs Market Research Report 2023

Report ID: 1974680 | Published Date: Sep 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Inhalable Drugs Market Overview
    1.1 Product Overview and Scope of Inhalable Drugs
    1.2 Inhalable Drugs Segment by Type
        1.2.1 Global Inhalable Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Suspension Aerosol
        1.2.3 Solution Aerosol
        1.2.4 Dry Powder Formulation
    1.3 Inhalable Drugs Segment by Application
        1.3.1 Global Inhalable Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Respiratory Diseases
        1.3.3 Non-respiratory Diseases
    1.4 Global Inhalable Drugs Market Size Estimates and Forecasts
        1.4.1 Global Inhalable Drugs Revenue 2017-2028
        1.4.2 Global Inhalable Drugs Sales 2017-2028
        1.4.3 Inhalable Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Inhalable Drugs Market Competition by Manufacturers
    2.1 Global Inhalable Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Inhalable Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Inhalable Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Inhalable Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Inhalable Drugs Market Competitive Situation and Trends
        2.5.1 Inhalable Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Inhalable Drugs Players Market Share by Revenue
        2.5.3 Global Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalable Drugs Retrospective Market Scenario by Region
    3.1 Global Inhalable Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Inhalable Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Inhalable Drugs Market Facts & Figures by Country
        3.3.1 North America Inhalable Drugs Sales by Country
        3.3.2 North America Inhalable Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Inhalable Drugs Market Facts & Figures by Country
        3.4.1 Europe Inhalable Drugs Sales by Country
        3.4.2 Europe Inhalable Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Inhalable Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Inhalable Drugs Sales by Region
        3.5.2 Asia Pacific Inhalable Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Inhalable Drugs Market Facts & Figures by Country
        3.6.1 Latin America Inhalable Drugs Sales by Country
        3.6.2 Latin America Inhalable Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Inhalable Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Inhalable Drugs Sales by Country
        3.7.2 Middle East and Africa Inhalable Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Inhalable Drugs Historic Market Analysis by Type
    4.1 Global Inhalable Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Inhalable Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Inhalable Drugs Price by Type (2017-2022)
5 Global Inhalable Drugs Historic Market Analysis by Application
    5.1 Global Inhalable Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Inhalable Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Inhalable Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 NanoDerma
        6.1.1 NanoDerma Corporation Information
        6.1.2 NanoDerma Description and Business Overview
        6.1.3 NanoDerma Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 NanoDerma Inhalable Drugs Product Portfolio
        6.1.5 NanoDerma Recent Developments/Updates
    6.2 Pfizer
        6.2.1 Pfizer Corporation Information
        6.2.2 Pfizer Description and Business Overview
        6.2.3 Pfizer Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Pfizer Inhalable Drugs Product Portfolio
        6.2.5 Pfizer Recent Developments/Updates
    6.3 Aradigm Corporation
        6.3.1 Aradigm Corporation Corporation Information
        6.3.2 Aradigm Corporation Description and Business Overview
        6.3.3 Aradigm Corporation Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Aradigm Corporation Inhalable Drugs Product Portfolio
        6.3.5 Aradigm Corporation Recent Developments/Updates
    6.4 Alkerme
        6.4.1 Alkerme Corporation Information
        6.4.2 Alkerme Description and Business Overview
        6.4.3 Alkerme Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Alkerme Inhalable Drugs Product Portfolio
        6.4.5 Alkerme Recent Developments/Updates
    6.5 Dura Pharmaceuticals
        6.5.1 Dura Pharmaceuticals Corporation Information
        6.5.2 Dura Pharmaceuticals Description and Business Overview
        6.5.3 Dura Pharmaceuticals Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Dura Pharmaceuticals Inhalable Drugs Product Portfolio
        6.5.5 Dura Pharmaceuticals Recent Developments/Updates
    6.6 AeroGen and Inhale Therapeutic Systems
        6.6.1 AeroGen and Inhale Therapeutic Systems Corporation Information
        6.6.2 AeroGen and Inhale Therapeutic Systems Description and Business Overview
        6.6.3 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product Portfolio
        6.6.5 AeroGen and Inhale Therapeutic Systems Recent Developments/Updates
7 Inhalable Drugs Manufacturing Cost Analysis
    7.1 Inhalable Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Inhalable Drugs
    7.4 Inhalable Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Inhalable Drugs Distributors List
    8.3 Inhalable Drugs Customers
9 Inhalable Drugs Market Dynamics
    9.1 Inhalable Drugs Industry Trends
    9.2 Inhalable Drugs Market Drivers
    9.3 Inhalable Drugs Market Challenges
    9.4 Inhalable Drugs Market Restraints
10 Global Market Forecast
    10.1 Inhalable Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Inhalable Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Inhalable Drugs by Type (2023-2028)
    10.2 Inhalable Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Inhalable Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Inhalable Drugs by Application (2023-2028)
    10.3 Inhalable Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Inhalable Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Inhalable Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Inhalable Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Inhalable Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Inhalable Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Inhalable Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Inhalable Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Inhalable Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Inhalable Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Inhalable Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Inhalable Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Inhalable Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Inhalable Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Inhalable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalable Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Inhalable Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Inhalable Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Inhalable Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Inhalable Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Inhalable Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Inhalable Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Inhalable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Inhalable Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Inhalable Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Inhalable Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Inhalable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Inhalable Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Inhalable Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Inhalable Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Inhalable Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Inhalable Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Inhalable Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Inhalable Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Inhalable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Inhalable Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Inhalable Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Inhalable Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Inhalable Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Inhalable Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Inhalable Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Inhalable Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Inhalable Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Inhalable Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Inhalable Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Inhalable Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Inhalable Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Inhalable Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Inhalable Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Inhalable Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. NanoDerma Corporation Information
    Table 50. NanoDerma Description and Business Overview
    Table 51. NanoDerma Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. NanoDerma Inhalable Drugs Product
    Table 53. NanoDerma Recent Developments/Updates
    Table 54. Pfizer Corporation Information
    Table 55. Pfizer Description and Business Overview
    Table 56. Pfizer Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Pfizer Inhalable Drugs Product
    Table 58. Pfizer Recent Developments/Updates
    Table 59. Aradigm Corporation Corporation Information
    Table 60. Aradigm Corporation Description and Business Overview
    Table 61. Aradigm Corporation Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Aradigm Corporation Inhalable Drugs Product
    Table 63. Aradigm Corporation Recent Developments/Updates
    Table 64. Alkerme Corporation Information
    Table 65. Alkerme Description and Business Overview
    Table 66. Alkerme Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Alkerme Inhalable Drugs Product
    Table 68. Alkerme Recent Developments/Updates
    Table 69. Dura Pharmaceuticals Corporation Information
    Table 70. Dura Pharmaceuticals Description and Business Overview
    Table 71. Dura Pharmaceuticals Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Dura Pharmaceuticals Inhalable Drugs Product
    Table 73. Dura Pharmaceuticals Recent Developments/Updates
    Table 74. AeroGen and Inhale Therapeutic Systems Corporation Information
    Table 75. AeroGen and Inhale Therapeutic Systems Description and Business Overview
    Table 76. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Product
    Table 78. AeroGen and Inhale Therapeutic Systems Recent Developments/Updates
    Table 79. Production Base and Market Concentration Rate of Raw Material
    Table 80. Key Suppliers of Raw Materials
    Table 81. Inhalable Drugs Distributors List
    Table 82. Inhalable Drugs Customers List
    Table 83. Inhalable Drugs Market Trends
    Table 84. Inhalable Drugs Market Drivers
    Table 85. Inhalable Drugs Market Challenges
    Table 86. Inhalable Drugs Market Restraints
    Table 87. Global Inhalable Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 88. Global Inhalable Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Inhalable Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 90. Global Inhalable Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Inhalable Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 92. Global Inhalable Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Inhalable Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 94. Global Inhalable Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Global Inhalable Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 96. Global Inhalable Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 97. Global Inhalable Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 98. Global Inhalable Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Inhalable Drugs
    Figure 2. Global Inhalable Drugs Market Share by Type in 2021 & 2028
    Figure 3. Suspension Aerosol Product Picture
    Figure 4. Solution Aerosol Product Picture
    Figure 5. Dry Powder Formulation Product Picture
    Figure 6. Global Inhalable Drugs Market Share by Application in 2021 & 2028
    Figure 7. Respiratory Diseases
    Figure 8. Non-respiratory Diseases
    Figure 9. Global Inhalable Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Inhalable Drugs Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Inhalable Drugs Sales (2017-2028) & (K Units)
    Figure 12. Inhalable Drugs Sales Share by Manufacturers in 2021
    Figure 13. Global Inhalable Drugs Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Inhalable Drugs Players: Market Share by Revenue in 2021
    Figure 15. Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Inhalable Drugs Sales Market Share by Region (2017-2022)
    Figure 17. Global Inhalable Drugs Sales Market Share by Region in 2021
    Figure 18. Global Inhalable Drugs Revenue Market Share by Region (2017-2022)
    Figure 19. Global Inhalable Drugs Revenue Market Share by Region in 2021
    Figure 20. U.S. Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Taiwan Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Philippines Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Vietnam Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. U.A.E Inhalable Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Inhalable Drugs by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Inhalable Drugs
    Figure 46. Manufacturing Process Analysis of Inhalable Drugs
    Figure 47. Inhalable Drugs Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
NanoDerma
Pfizer
Aradigm Corporation
Alkerme
Dura Pharmaceuticals
AeroGen and Inhale Therapeutic Systems
Frequently Asked Questions
Inhalable Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inhalable Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inhalable Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports